C

Caregen Co Ltd
KOSDAQ:214370

Watchlist Manager
Caregen Co Ltd
KOSDAQ:214370
Watchlist
Price: 22 200 KRW -3.48% Market Closed
Market Cap: 1.1T KRW
Have any thoughts about
Caregen Co Ltd?
Write Note

Caregen Co Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Caregen Co Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
C
Caregen Co Ltd
KOSDAQ:214370
Cash & Cash Equivalents
â‚©8.4B
CAGR 3-Years
1 003%
CAGR 5-Years
430%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Cash & Cash Equivalents
â‚©229.7B
CAGR 3-Years
5%
CAGR 5-Years
-3%
CAGR 10-Years
3%
SK Biopharmaceuticals Co Ltd
KRX:326030
Cash & Cash Equivalents
â‚©239.7B
CAGR 3-Years
59%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Cash & Cash Equivalents
â‚©47.9B
CAGR 3-Years
-35%
CAGR 5-Years
-11%
CAGR 10-Years
-4%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Cash & Cash Equivalents
â‚©134B
CAGR 3-Years
28%
CAGR 5-Years
17%
CAGR 10-Years
14%
C
Celltrion Pharm Inc
KOSDAQ:068760
Cash & Cash Equivalents
â‚©28.1B
CAGR 3-Years
-23%
CAGR 5-Years
66%
CAGR 10-Years
28%
No Stocks Found

Caregen Co Ltd
Glance View

Market Cap
1.1T KRW
Industry
Pharmaceuticals

Caregen Co., Ltd. engages in the development of cosmetic products. The company is headquartered in Anyang, Gyeonggi-Do. The company went IPO on 2015-11-17. The firm manufactures HSR CEs which used for improving facial wrinkles and strengthening protect wet under the brand name of Dermaheal, aquashines which used for keeping the shin whitening and promoting skin cells activation under the brand name of REVOFIL, HL CEs which used for treating hair loss, hair filler excell C'rums which used for promoting hair growth and preventing hair lose, LL CEs which used for promoting fat decomposition and prevent fat accumulation, hydra B5 Gels, ultra AW500s, eye filler masks, efficacy raw materials including growth facors and biomimetic peptides, and others. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
13 853.64 KRW
Overvaluation 38%
Intrinsic Value
Price
C

See Also

What is Caregen Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
8.4B KRW

Based on the financial report for Jun 30, 2024, Caregen Co Ltd's Cash & Cash Equivalents amounts to 8.4B KRW.

What is Caregen Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
430%

Over the last year, the Cash & Cash Equivalents growth was -85%. The average annual Cash & Cash Equivalents growth rates for Caregen Co Ltd have been 1 003% over the past three years , 430% over the past five years .

Back to Top